Future cardiology最新文献_第9页

Outcomes of mitral valve transcatheter edge to edge repair in patients with coronary chronic total occlusion. 冠状动脉慢性全闭塞患者二尖瓣经导管边缘修补术的疗效。

IF 1.6

Future cardiology Pub Date : 2024-12-01 Epub Date: 2024-11-27 DOI: 10.1080/14796678.2024.2434392

Asmaa Ahmed, Mahmoud Eisa, Andrew Takla, Sahej Arora, Mohamed Mohamed, Amir Hanafi, Scott Feitell

{"title":"Outcomes of mitral valve transcatheter edge to edge repair in patients with coronary chronic total occlusion.","authors":"Asmaa Ahmed, Mahmoud Eisa, Andrew Takla, Sahej Arora, Mohamed Mohamed, Amir Hanafi, Scott Feitell","doi":"10.1080/14796678.2024.2434392","DOIUrl":"10.1080/14796678.2024.2434392","url":null,"abstract":"Introduction: It remains unknown whether the concomitant coronary chronic total occlusion (CTO) would affect the outcomes of the Mitral valve Trans-catheter Edge to edge-to-edge repair (M-TEER) procedure.Methodology: Study population was extracted from the Nationwide Inpatient Sample Data using the International Classification of Diseases and clinical modifications/procedure coding system codes for M-TEER and CTO. Primary outcomes were in-hospital all-cause mortality and net cardiac periprocedural complications. Propensity matching was used to extract a matched control (M-TEER-CTO and M-TEER-No CTO).Results: A total of 48,835 cases of M-TEER were identified in the United States between January 2016 and December 2020, of whom 700 patients (1.5%) had the diagnosis of coronary total occlusion (CTO). The mean age of M-TEER patients was not significantly different between the two groups (76 vs. 75 years, p = 0.11); however, the CTO cohort had a higher percentage of males (66.72% vs. 53.41%, p = 0.002). M-TEER-CTO had higher odds of net all cardiac periprocedural complications (aOR 1.83,95% CI (1.17-2.84), p = 0.007) compared to the no-CTO group, however, there was no difference in in-hospital mortality (aOR 1.54, 95%CI (0.52-4.56), p = 0.43).Conclusions: Patients undergoing M-TEER with CTO had a higher incidence of net all cardiac periprocedural complications but similar mortality compared to those with no CTO.","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"843-847"},"PeriodicalIF":1.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11730769/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142727631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Defining, measuring, and addressing medication non-adherence in cardiovascular disease. 心血管疾病中药物依从性的定义、测量和处理。

IF 1.6

Future cardiology Pub Date : 2024-12-01 Epub Date: 2024-11-29 DOI: 10.1080/14796678.2024.2433888

Adam C Livori, Lachlan Dalli, Stephen J Nicholls, Adam J Nelson

引用次数: 0

Operation in the gray zone: is SAVR still useful in patients aged between 75 and 80 years? 灰色地带的手术：SAVR 对 75 至 80 岁的患者是否仍然有用？

IF 1.6

Future cardiology Pub Date : 2024-12-01 Epub Date: 2024-11-25 DOI: 10.1080/14796678.2024.2433827

Ivo Deblier, Karl Dossche, Anthony Vanermen, Wilhelm Mistiaen

{"title":"Operation in the gray zone: is SAVR still useful in patients aged between 75 and 80 years?","authors":"Ivo Deblier, Karl Dossche, Anthony Vanermen, Wilhelm Mistiaen","doi":"10.1080/14796678.2024.2433827","DOIUrl":"10.1080/14796678.2024.2433827","url":null,"abstract":"Introduction: Aortic valve replacement is the only effective treatment for symptomatic aortic valve disease. Transcatheter implantation has been introduced as alternative for surgery (SAVR), but its penetration varied widely. For high-risk octogenarian patients, the advantages of TAVI are clear. Patients between 75 and 79 years of age could be considered as \"the gray zone.\"Methods: We compared the outcome of SAVR with or without concomitant procedures between patients younger than 75 versus 75-79 years for their preoperative profile, operative parameters, and postoperative outcomes.Results: Older patients had a higher risk score with more cardiovascular comorbidity and renal dysfunction. They required more concomitant CABG but less mitral valve repair. Cardiopulmonary bypass time was similar. In-hospital complication rates, need for blood transfusion, and length of stay in intensive care unit were higher in older patients. Thirty-day mortality was not significantly increased, Euroscore II overestimated mortality in both age groups. Age over 75 years was not an independent predictor for mortality. Need for emergent SAVR was only predictive in the older group. Long-term survival was acceptable. Age over 75 years was not the dominant predictor.Conclusions: SAVR remains a valid option to treat symptomatic aortic valve disease in the age group of 75-79.","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"849-858"},"PeriodicalIF":1.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11734591/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142709869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Genetics in clinical cardiology: the current state and opportunities ahead. 临床心脏病学中的遗传学：现状与机遇。

IF 1.6

Future cardiology Pub Date : 2024-12-01 Epub Date: 2024-11-14 DOI: 10.1080/14796678.2024.2426883

Anjali Agarwalla, Melissa A Austin, Nosheen Reza

引用次数: 0

Soft drinks, fish oil and atrial fibrillation. 软饮料、鱼油和心房颤动

IF 1.6

Future cardiology Pub Date : 2024-12-01 Epub Date: 2024-11-18 DOI: 10.1080/14796678.2024.2420552

Gorm Boje Jensen, Peter Schnohr, Carl J Lavie, James H O'Keefe

引用次数: 0

Long-term clinical and angiographic outcome of T-and protrusion technique with ultrathin strut drug eluting stents. t -突出技术与超薄支撑物药物洗脱支架的长期临床和血管造影结果。

IF 1.6

Future cardiology Pub Date : 2024-12-01 Epub Date: 2024-12-04 DOI: 10.1080/14796678.2024.2435205

Csaba A Dézsi, Judit Andréka, Amer M Sayour, Mónika Deák, Veronika Szentes, Zoltán Sebők, Zsolt Fi, Alexandru Achim, Zoltán Ruzsa

{"title":"Long-term clinical and angiographic outcome of T-and protrusion technique with ultrathin strut drug eluting stents.","authors":"Csaba A Dézsi, Judit Andréka, Amer M Sayour, Mónika Deák, Veronika Szentes, Zoltán Sebők, Zsolt Fi, Alexandru Achim, Zoltán Ruzsa","doi":"10.1080/14796678.2024.2435205","DOIUrl":"10.1080/14796678.2024.2435205","url":null,"abstract":"Objectives: Data about coronary bifurcations treated with ultrathin strut drug-eluting stents (DES) using T-and-protrusion (TAP) technique is limited.Methods: In this study, a total of 84 consecutive patients, who underwent bifurcation percutaneous coronary intervention (PCI) with TAP technique using Orsiro® DES (Biotronik, Berlin, Germany), were included. All pre- and post-procedural data, as well as 1- and 2-year follow-up angiograms, were analyzed. Primary endpoints were procedural success and target lesion failure (TLF); secondary endpoints were all-cause mortality and major adverse cardiac and cerebrovascular events (MACCE) during follow-up.Results: Procedural success was achieved in 100% of cases. TLF rate was higher in patients presented with acute coronary syndrome compared to the ones with chronic coronary syndrome (19% vs. 5% p = 0.09). All-cause mortality was 30% during follow-up, from which 26% was due to non-cardiovascular cause, and the MACCE rate was 46%.Conclusions: Coronary bifurcations treated with ultrathin strut DES showed good short-term results and were associated with acceptable cardiovascular mortality. However, in these long-term patients, the rate of MACCE and non-cardiovascular death were rather high.","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"837-842"},"PeriodicalIF":1.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11731050/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142768059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Rotational atherectomy with cutting balloon before stenting in severely calcified coronary lesions: a meta-analysis. 在严重钙化的冠状动脉病变中，支架置入前采用球囊切割旋转动脉粥样硬化切除术：一项荟萃分析。

IF 1.6

Future cardiology Pub Date : 2024-12-01 Epub Date: 2024-12-12 DOI: 10.1080/14796678.2024.2440220

Obieda Altobaishat, Mohamed Abouzid, Mohammad Tanashat, Ahmed Mazen Amin, Mustafa Turkmani, Mohamed Abuelazm

{"title":"Rotational atherectomy with cutting balloon before stenting in severely calcified coronary lesions: a meta-analysis.","authors":"Obieda Altobaishat, Mohamed Abouzid, Mohammad Tanashat, Ahmed Mazen Amin, Mustafa Turkmani, Mohamed Abuelazm","doi":"10.1080/14796678.2024.2440220","DOIUrl":"10.1080/14796678.2024.2440220","url":null,"abstract":"Background: Rotational atherectomy (RA) has been proven to treat coronary artery calcification (CAC) during percutaneous coronary intervention (PCI).Purpose: This study evaluates the safety and efficacy of RA followed by cutting balloon angioplasty (ROTACUT) before stent placement in CAC.Methods: A systematic review and meta-analysis of randomized controlled trials and observational studies was conducted. PubMed, Web of Science, Scopus, and Cochrane were searched through January 2024. We used Stata version 17 to pool dichotomous data using risk ratio (RR) and continuous data using mean difference (MD), with a 95% confidence interval (CI).Results: Eight studies with 846 patients were included. There was no significant difference between ROTACUT and RA + bare balloons in major adverse cardiovascular events (MACE) (RR:0.60; 95%CI [0.31,1.16], p = 0.13), cardiac death (RR:1.32; 95%CI [0.42,4.14], p = 0.64), target vessel revascularization (TVR) (RR:1.89; 95%CI [0.40,8.84], p = 0.42), target lesion revascularization (TLR) (RR:0.83; 95%CI [0.39,1.79], p = 0.64), procedural duration (MD:0.78; 95%CI [-4.68,6.24], p = 0.78), stent thrombosis (RR:0.81; 95%CI [0.22,2.95], p = 0.75), and any procedure-related complications (RR:0.86; 95%CI [0.42,1.75], p = 0.68).Conclusion: ROTACUT and RA + bare balloons demonstrated similar efficacy and safety profiles regarding MACE, cardiac death, TVR, TLR, procedural duration, stent thrombosis, and all safety outcomes.","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"859-870"},"PeriodicalIF":1.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11731055/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142817561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Maternal cardiac arrest: the present and the future. 孕产妇心脏骤停：现状与未来。

IF 1.7

Future cardiology Pub Date : 2024-04-30 DOI: 10.2217/fca-2024-0042

Sanjana Nagraj, Steve Kong